The product has significant immune mediated neuro-protective activities for acute and chronic neuro-degenerative conditions, including glaucoma, spinal cord injury etc.
Therapies
Proneuron Biotechnologies: Treatment for Spinal Cord Injury and other Neurological Disorders
Home Page
   Company
 
      Technology
 
       Therapies
 
       Clinical Studies
 
      News & Events
 
     Links
 
   Careers
 
PN277 immune modulator
Proneuron's PN277 is a lead product candidate found to have significant immune mediated neuro-protective activities in several preclinical studies for acute and chronic neuro-degenerative conditions, including glaucoma, spinal cord injury, optic nerve injury, stroke and potentially other neurodegenerative disorders. PN277 represents a new generation of neuro-protective products in that it:
  • activates the body's own mechanism for healing and repair in the damaged CNS
  • has neuro-protective activity which targets damaged tissue only
  • has a long lasting neuro-protective effect that has been demonstrated in vitro and in vivo with no side effects observed
  • has broad neuro-protective activities that minimizes neuronal loss
Proneuron is seeking a strategic partner with extensive experience in the formulation, development and commercialization of therapeutic products for the rapid development of PN277 for stroke and glaucoma.


Disclaimer | Site Map | Home Page| Contact Us Top of page
 

Proneuron Biotechnologies is engaged in research
related to spinal cord injuries and paralysis cure.
























Our friends on the web
Judaica Shop
Spinal Cord Injury
Virtual Keyboard
Spinal Cord Injuries
Flowers Israel
Mobile NoteTaker
Marine Construction
Australia Flowers
Rugged Computers
Mobile Phone Disabler
Digital Pen